Akihiro Kitadate

Akita, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Ocular Follicular Lymphoma with Marginal Zone Differentiation: A Diagnostic Pitfall Mimicking MALT Lymphoma.

Ocular Follicular Lymphoma with Marginal Zone Differentiation: A Diagnostic Pitfall Mimicking MALT Lymphoma.

Journal: Internal medicine (Tokyo, Japan)

Published: July 20, 2026

Impact of Transplant Type on Infection Risk in Studies of Neutropenic Diets.

Impact of Transplant Type on Infection Risk in Studies of Neutropenic Diets.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 01, 2026

Patient selection and treatment sequencing in RESMAIN.

Patient selection and treatment sequencing in RESMAIN.

Journal: The Lancet. Haematology

Published: February 18, 2026

Pseudoprogression after CAR T-cell therapy mimicking orbital lymphoma relapse.

Pseudoprogression after CAR T-cell therapy mimicking orbital lymphoma relapse.

Journal: QJM : monthly journal of the Association of Physicians

Published: January 26, 2026

Treatment strategies for multiple myeloma based on molecular biology and cytogenetic abnormalities

Treatment strategies for multiple myeloma based on molecular biology and cytogenetic abnormalities

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: October 01, 2025

Clinical Practice of Treatment Switch in Transplant-eligible Patients with Multiple Myeloma: An Exploratory Retrospective Analysis.

Clinical Practice of Treatment Switch in Transplant-eligible Patients with Multiple Myeloma: An Exploratory Retrospective Analysis.

Journal: Internal medicine (Tokyo, Japan)

Published: September 18, 2025

NF-κB Is a Potential Therapeutic Target for Histone Deacetylase Inhibitor-Resistant Cutaneous T-Cell Lymphoma.

NF-κB Is a Potential Therapeutic Target for Histone Deacetylase Inhibitor-Resistant Cutaneous T-Cell Lymphoma.

Journal: Cancer science

Published: June 16, 2025

Successful Salvage Therapy with Pomalidomide, Cyclophosphamide, and Dexamethasone for IgM Myeloma with t (11;14) and Dim CD38 Expression Refractory to Daratumumab, Lenalidomide, and Dexamethasone.

Successful Salvage Therapy with Pomalidomide, Cyclophosphamide, and Dexamethasone for IgM Myeloma with t (11;14) and Dim CD38 Expression Refractory to Daratumumab, Lenalidomide, and Dexamethasone.

Journal: Internal medicine (Tokyo, Japan)

Published: April 29, 2025

Multiple myeloma with 1q gain/amplification exhibits reduced CD38 expression via interleukin-6 receptor overexpression.

Multiple myeloma with 1q gain/amplification exhibits reduced CD38 expression via interleukin-6 receptor overexpression.

Journal: British journal of haematology

Published: November 21, 2024

Comprehensive analysis of microRNAs modulated by histone deacetylase inhibitors identifies microRNA-7-5p with anti-myeloma effect.

Comprehensive analysis of microRNAs modulated by histone deacetylase inhibitors identifies microRNA-7-5p with anti-myeloma effect.

Journal: International journal of hematology

Published: February 08, 2024

Successful cord blood transplantation for refractory gamma-delta hepatosplenic T-cell lymphoma developed during treatment of Crohn's disease

Successful cord blood transplantation for refractory gamma-delta hepatosplenic T-cell lymphoma developed during treatment of Crohn's disease

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: February 04, 2024

Ponatinib Improved the Prognosis of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Japanese Single-Center Cohort Study.

Ponatinib Improved the Prognosis of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Japanese Single-Center Cohort Study.

Journal: Cureus

Published: December 12, 2023

Showing 1-12 of 56

Last Updated: 09/26/2026